← TrialMatch
HomeTrials

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Aud

This is a combination of retrospective and prospective observational study that will be performed across NCG and other participating centers to report compliance to chemoradiation for cervical cancer. This audit will include patients treated with standard of care treatment, in this case definitive or adjuvant radiation

Condition(s)Cervical Cancer Screening, Gynecologic Cancers, Treatment Compliance, Chemoradiotherapy
StatusRecruiting
Study typeObservational
SummaryThis is a combination of retrospective and prospective observational study that will be performed across NCG and other participating centers to report compliance to chemoradiation for cervical cancer. This audit will include patients treated with standard of care treatment, in this case definitive or adjuvant radiation+/- concurrent chemotherapy will be included. Patients recruited in various institutions in prospective clinical trials will not be included. The participating centersthat agree to contribute data will include all registered cases over a 6-month period that have been diagnosed with cervical cancer wherein treatment is planned with radical dose radiation and/or concurrent chemotherapy. Centers that do not have retrospective data of the patients will contribute data of patients
Who can participateThe participating centers that agree to contribute data will include all registered cases over a 6 month period that have been diagnosed with histologically proven cervical cancer wherein either radical, adjuvant or palliative radiation with or without concurrent or systemic chemotherapy is planned. Furthermore any cases referred to the institution for brachytherapy alone will also be included.
SexFemale
Lead sponsorTata Memorial Hospital
LocationsMumbai, Maharashtra, India; Mumbai, Maharashtra, India
Start date2021-02-01
NCT IDNCT07290972
Official listinghttps://clinicaltrials.gov/study/NCT07290972

🔍 Search all trials →